SANESE, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 2.015
AS - Asia 802
EU - Europa 735
SA - Sud America 230
Continente sconosciuto - Info sul continente non disponibili 152
AF - Africa 66
OC - Oceania 4
Totale 4.004
Nazione #
US - Stati Uniti d'America 1.904
SG - Singapore 329
IT - Italia 298
BR - Brasile 188
CN - Cina 139
RU - Federazione Russa 104
VN - Vietnam 102
HK - Hong Kong 95
DE - Germania 75
CA - Canada 58
GB - Regno Unito 55
SE - Svezia 49
FR - Francia 39
CI - Costa d'Avorio 31
BD - Bangladesh 27
IN - India 27
FI - Finlandia 26
PL - Polonia 17
ID - Indonesia 16
AT - Austria 14
NL - Olanda 13
ZA - Sudafrica 12
CO - Colombia 11
MX - Messico 11
TR - Turchia 11
LT - Lituania 10
AR - Argentina 9
EC - Ecuador 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
IQ - Iraq 8
JP - Giappone 8
GT - Guatemala 7
PK - Pakistan 7
VE - Venezuela 6
BE - Belgio 5
CR - Costa Rica 5
ES - Italia 5
JM - Giamaica 5
KE - Kenya 5
NI - Nicaragua 5
SV - El Salvador 5
AU - Australia 4
GP - Guadalupe 3
MA - Marocco 3
MY - Malesia 3
NG - Nigeria 3
PY - Paraguay 3
UA - Ucraina 3
UZ - Uzbekistan 3
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
IE - Irlanda 2
KN - Saint Kitts e Nevis 2
KW - Kuwait 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GN - Guinea 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
LC - Santa Lucia 1
ML - Mali 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SC - Seychelles 1
SO - Somalia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.854
Città #
Ashburn 287
San Jose 193
Singapore 178
Fairfield 136
Hong Kong 94
Chandler 88
Milan 81
Houston 64
Woodbridge 61
Beijing 60
Council Bluffs 59
Seattle 50
New York 47
Los Angeles 45
Cambridge 43
Nyköping 39
Munich 35
Santa Clara 35
Rome 34
Wilmington 34
Abidjan 31
Dallas 28
Boardman 21
Ho Chi Minh City 20
Toronto 19
Columbus 18
Lauterbourg 18
Brooklyn 17
Frankfurt am Main 17
Hanoi 17
Helsinki 17
Dong Ket 16
Bari 15
Jakarta 14
London 14
Warsaw 14
São Paulo 13
Roxbury 12
Chicago 11
Montreal 11
Atlanta 10
Buffalo 10
Indianapolis 10
Inglewood 10
Orem 10
Chennai 9
Des Moines 9
Turku 9
Lawrence 8
Olomouc 8
San Francisco 8
Tokyo 8
Johannesburg 7
Nuremberg 7
Phoenix 7
Denver 6
Mexico City 6
North Bergen 6
Philadelphia 6
Stockholm 6
Ann Arbor 5
Brussels 5
Düsseldorf 5
Figino 5
Guatemala City 5
Haiphong 5
Moscow 5
Nairobi 5
Nanjing 5
San Salvador 5
Vilnius 5
Ankara 4
Baghdad 4
Barnet 4
Bauru 4
Belo Horizonte 4
Bexley 4
Cagliari 4
Dearborn 4
Falkenstein 4
Guayaquil 4
Jeddah 4
Kingston 4
Las Vegas 4
Managua 4
Manchester 4
Miami 4
Mumbai 4
Noicattaro 4
Poplar 4
Porto Alegre 4
Redwood City 4
Rio de Janeiro 4
Riyadh 4
San Diego 4
San José 4
Uberlândia 4
Amsterdam 3
Bogotá 3
Bologna 3
Totale 2.334
Nome #
A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth 228
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 222
The longevity SNP rs2802292 uncovered: HSF1 activates stress-dependent expression of FOXO3 through an intronic enhancer. 214
Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy. 204
FOXO3 on the Road to Longevity: Lessons From SNPs and Chromatin Hubs 199
Gastric polyposis and desmoid tumours as a new familial adenomatous polyposis clinical variant associated with APC mutation at the extreme 3′-end 185
In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS) 181
Chasing the Foxo3: Insights into its new mitochondrial lair in colorectal cancer landscape 168
Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality 134
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype 129
Playing on the dark side: Smyd3 acts as a cancer genome keeper in gastrointestinal malignancies 121
Discovery of an allosteric ligand binding site in SMYD3 lysine methyltransferase 115
Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3 109
Identification and Somatic Characterization of the Germline PTEN Promoter Variant rs34149102 in a Family with Gastrointestinal and Breast Tumors 109
SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage 107
Identifying novel SMYD3 interactors on the trail of cancer hallmarks 106
Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review 104
Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities 102
SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer 98
Coinheritance of germline mutations in APC and MUTYH genes defines the clinical outcome of adenomatous polyposis syndromes 97
c-MYC Protein Stability Is Sustained by MAPKs in Colorectal Cancer 95
Identification of a novel germline APC N-terminal pathogenic variant associated with attenuated familial adenomatous polyposis 91
The chromatin remodeling factors EP300 and TRRAP are novel SMYD3 interactors involved in the emerging 'nonmutational epigenetic reprogramming' cancer hallmark 91
Tumor Testing and Genetic Analysis to Identify Lynch Syndrome Patients in an Italian Colorectal Cancer Cohort 91
Classic Galactosemia: Clinical and Computational Characterization of a Novel GALT Missense Variant (p.A303D) and a Literature Review 88
Clinical and Molecular Characterization of SMAD4 Splicing Variants in Patients with Juvenile Polyposis Syndrome 81
Uncoupling p38α nuclear and cytoplasmic functions and identification of two p38α phosphorylation sites on β-catenin: implications for the Wnt signaling pathway in CRC models 79
Exploring the Relationship of rs2802292 with Diabetes and NAFLD in a Southern Italian Cohort-Nutrihep Study 78
In Silico Deciphering of the Potential Impact of Variants of Uncertain Significance in Hereditary Colorectal Cancer Syndromes 70
Pharmacological targeting of the novel β-catenin chromatin-associated kinase p38α in colorectal cancer stem cell tumorspheres and organoids 57
Methyltransferases in cancer drug resistance: Unlocking the potential of targeting SMYD3 to sensitize cancer cells 40
Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis 39
Deciphering the Causative Role of a Novel APC Gene Variant in Attenuated Familial Adenomatous Polyposis Using Germline DNA-RNA Paired Testing 37
The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance 35
An Integrated Clinical, Germline, Somatic, and In Silico Approach to Assess a Novel PMS2 Gene Variant Identified in Two Unrelated Lynch Syndrome Families 32
Clinical Assessment and Genetic Testing for Hereditary Polyposis Syndromes in an Italian Cohort of Patients with Colorectal Polyps 32
The Interplay of Genetics and Lifestyle in MASLD: Focus on LPIN1 rs13412852 and Sedentary Behaviour 22
The Protective Effect of FOXO3 rs2802292 G-Allele on Food Intake in a Southern Italian Cohort Affected by MASLD 14
Totale 4.004
Categoria #
all - tutte 14.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.756


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202298 0 0 0 0 4 12 3 6 8 14 16 35
2022/2023189 12 33 14 13 13 32 1 26 39 1 3 2
2023/2024100 2 12 1 5 8 31 4 6 1 10 7 13
2024/2025644 25 9 42 29 23 66 77 61 25 42 69 176
2025/20261.791 226 113 148 158 202 67 112 20 234 229 96 186
2026/2027624 63 158 195 204 4 0 0 0 0 0 0 0
Totale 4.004